Evidence map›Paper›PMID 23071529›Full record

ArticlePloS one2012

A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo.

Laura S Weyrich, Olivier Y Rolin, Sarah J Muse, Jihye Park, Nicholas Spidale, Mary J Kennett, Sara E Hester, Chun Chen, Edward G Dudley, Eric T Harvill

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. mSphere · 2026
    Article
  2. Review
  3. Review
  4. Differences in the effects ofFrontiers in pediatrics · 2023
    Article
  5. Frontiers in cellular and infection microbiology · 2023
    Article
  6. Canine Infectious Respiratory Disease.The Veterinary clinics of North America. Small animal practice · 2020
    Review
  7. Two Type VI Secretion Systems ofFrontiers in microbiology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. RespiratoryInternational journal of molecular sciences · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Laura S WeyrichDepartment of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
Olivier Y Rolin
Sarah J Muse
Jihye Park
Nicholas Spidale
Mary J Kennett
Sara E Hester
Chun Chen
Edward G Dudley
Eric T Harvill
Pennsylvania State University · US

Funding

Evolution of the Bordetellae from Commensals to PathogensR01GM083113 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI HARVILL, ERIC T · 2008 to 2011
$2.1M
Comparative Immunobiology of the bordetellaeR01AI053075 · NIAID · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI HARVILL, ERIC T. · 2003 to 2007
$1.4M
Training in Animal Models of InflammationT32AI074551 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI GIBLIN, PAMELA A · 2011 to 2015
$940k
NIAID NIH HHS R01 AI053075NIAID NIH HHS T32 AI074551NIGMS NIH HHS GM083113NIGMS NIH HHS R01 GM083113
6 · The paper itself

Abstract

Type VI Secretion Systems (T6SSs) have been identified in numerous gram-negative pathogens, but the lack of a natural host infection model has limited analysis of T6SS contributions to infection and pathogenesis. Here, we describe disruption of a gene within locus encoding a putative T6SS in Bordetella bronchiseptica strain RB50, a respiratory pathogen that circulates in a broad range of mammals, including humans, domestic animals, and mice. The 26 gene locus encoding the B. bronchiseptica T6SS contains apparent orthologs to all known core genes and possesses thirteen novel genes. By generating an in frame deletion of clpV, which encodes a putative ATPase required for some T6SS-dependent protein secretion, we observe that ClpV contributes to in vitro macrophage cytotoxicity while inducing several eukaryotic proteins associated with apoptosis. Additionally, ClpV is required for induction of IL-1β, IL-6, IL-17, and IL-10 production in J774 macrophages infected with RB50. During infections in wild type mice, we determined that ClpV contributes to altered cytokine production, increased pathology, delayed lower respiratory tract clearance, and long term nasal cavity persistence. Together, these results reveal a natural host infection system in which to interrogate T6SS contributions to immunomodulation and pathogenesis.

Indexed as

Adenosine TriphosphatasesAnimalsBacterial ProteinsBordetella bronchisepticaBordetella InfectionsImmunomodulationInterleukin-17Interleukin-1betaInterleukin-6MacrophagesMiceMultigene FamilyUp-RegulationVirulenceVirulence FactorsAdenosine TriphosphatasesBacterial ProteinsInterleukin-17Interleukin-1betaInterleukin-6Virulence Factors

Identifiers

PMID23071529
PMCPMC3470547
OpenAlexW2014074767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.